logo
#

Latest news with #MokCFA

Barclays Remains a Buy on Cigna (CI)
Barclays Remains a Buy on Cigna (CI)

Business Insider

time05-05-2025

  • Business
  • Business Insider

Barclays Remains a Buy on Cigna (CI)

Barclays analyst Andrew Mok CFA maintained a Buy rating on Cigna (CI – Research Report) on May 2 and set a price target of $382.00. The company's shares closed last Friday at $334.75. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Mok CFA is an analyst with an average return of -10.9% and a 37.35% success rate. Mok CFA covers the Healthcare sector, focusing on stocks such as Humana, UnitedHealth, and Centene. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cigna with a $370.25 average price target. The company has a one-year high of $370.83 and a one-year low of $262.03. Currently, Cigna has an average volume of 1.8M.

Centene (CNC) Gets a Buy from Barclays
Centene (CNC) Gets a Buy from Barclays

Business Insider

time28-04-2025

  • Business
  • Business Insider

Centene (CNC) Gets a Buy from Barclays

Barclays analyst Andrew Mok CFA maintained a Buy rating on Centene (CNC – Research Report) on April 25 and set a price target of $84.00. The company's shares closed last Friday at $57.69. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. According to TipRanks, Mok CFA is an analyst with an average return of -10.9% and a 37.35% success rate. Mok CFA covers the Healthcare sector, focusing on stocks such as UnitedHealth, Centene, and Humana. In addition to Barclays, Centene also received a Buy from Wells Fargo's Stephen Baxter in a report issued on April 25. However, on the same day, Bank of America Securities maintained a Hold rating on Centene (NYSE: CNC). Based on Centene's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $46.62 billion and a net profit of $1.31 billion. In comparison, last year the company earned a revenue of $40.41 billion and had a net profit of $1.16 billion

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store